股票 › STOK
斯托克治疗 STOK
美股市值排名 #2835
$26.54 +$0.47 (+1.80%)
休市 · Nov 7, 5:10 am ET · 最新盘后价 $27.20 +2.49%
开盘$26.49
昨收$26.07
当日区间$25.96 – $26.72
成交量1.16M
市值$1.74B
市盈率（TTM）–
股息率–
STOK 相关新闻
匹配 Stoke Therapeutics 或代码 STOK 的头条新闻，按最新排序。
- A Quick Look at Today's Ratings for Stoke Therapeutics(STOK.US), With a Forecast Between $40 to $60
- Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FTRE) 正面
- Chardan Capital Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $35
- J.P. Morgan Upgrades Stoke Therapeutics(STOK.US) to Buy Rating, Raises Target Price to $40 正面
- CCORF Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $58
- Needham Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $40
- Jefferies Initiates Stoke Therapeutics(STOK.US) With Buy Rating, Announces Target Price $44
- Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK), Genelux Corp. (GNLX) and Celldex (CLDX)
- A Quick Look at Today's Ratings for Stoke Therapeutics(STOK.US), With a Forecast Between $38 to $60
- TD Cowen Maintains Stoke Therapeutics(STOK.US) With Buy Rating
- Guggenheim Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $60
- BTIG Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $39
- H.C. Wainwright Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $50
- CCORF Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Raises Target Price to $60 正面
- Wedbush Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $38
暂无评论——快来第一个聊聊 STOK。